CN Stock MarketDetailed Quotes

688139 Qingdao Haier Biomedical Co., Ltd.

Watchlist
  • 37.93
  • -1.07-2.74%
Trading Jun 27 13:04 CST
12.06BMarket Cap29.70P/E (TTM)

Qingdao Haier Biomedical Co., Ltd. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
0.04%686.91M
-20.36%2.28B
-12.00%1.83B
0.20%1.27B
21.87%686.67M
34.72%2.86B
36.52%2.08B
36.63%1.27B
36.22%563.45M
51.63%2.13B
Operating revenue
0.04%686.91M
-20.36%2.28B
-12.00%1.83B
0.20%1.27B
21.87%686.67M
34.72%2.86B
36.52%2.08B
36.63%1.27B
36.22%563.45M
51.63%2.13B
Total operating cost
-3.33%538.74M
-14.23%1.97B
-6.87%1.53B
5.84%1.03B
20.72%557.27M
35.84%2.29B
37.09%1.64B
38.19%977.88M
41.28%461.61M
56.00%1.69B
Operating cost
2.93%346.21M
-24.17%1.13B
-18.08%897.46M
-1.45%613.8M
20.67%336.35M
40.10%1.48B
46.09%1.1B
35.86%622.8M
35.37%278.74M
52.69%1.06B
Operating tax surcharges
-3.53%5.76M
-7.90%20.81M
-3.36%15.62M
22.04%11.68M
23.39%5.97M
41.05%22.6M
31.99%16.16M
34.10%9.57M
19.83%4.84M
22.97%16.02M
Operating expense
0.14%80.48M
-2.53%339.57M
5.53%251.8M
7.04%168.81M
1.29%80.36M
32.81%348.37M
27.15%238.61M
56.74%157.71M
38.44%79.34M
56.51%262.32M
Administration expense
-9.93%41.04M
10.95%183.47M
20.30%135.91M
28.57%93.72M
35.38%45.57M
31.53%165.35M
32.95%112.97M
29.28%72.89M
22.29%33.66M
76.68%125.71M
Financial expense
-233.31%-12M
-16.04%-23.53M
55.31%-14.89M
43.96%-10.63M
400.30%9M
-70.67%-20.28M
-187.28%-33.33M
-153.23%-18.97M
68.06%-3M
17.29%-11.88M
-Interest expense (Financial expense)
-5.12%842.63K
30.79%3.51M
51.37%2.85M
43.69%1.88M
35.56%888.12K
-7.16%2.69M
-16.86%1.88M
-20.35%1.31M
112.22%655.16K
3,369.39%2.89M
-Interest Income (Financial expense)
-92.47%-13.04M
-75.42%-35.61M
-54.94%-23.94M
-48.49%-14.58M
-37.38%-6.77M
-90.02%-20.3M
-102.51%-15.45M
-113.22%-9.82M
-195.22%-4.93M
54.03%-10.68M
Research and development
-3.44%77.26M
9.63%320.64M
14.87%242.65M
17.71%157.57M
17.62%80.01M
23.77%292.47M
21.40%211.25M
44.61%133.87M
64.55%68.02M
56.79%236.31M
Credit Impairment Loss
-14,151.72%-6.73M
-116.73%-2.42M
-223.37%-993.68K
-1,398.09%-431.24K
154.00%47.88K
-128.88%-1.12M
444.54%805.42K
-96.83%33.22K
104.39%18.85K
376.64%3.86M
Asset Impairment Loss
-102.29%-12.5K
69.64%-1.64M
34.34%-1.46M
39.43%-1.52M
174.90%545.75K
-307.43%-5.41M
-358.74%-2.22M
-544.18%-2.51M
-2,536.08%-728.65K
2.37%-1.33M
Other net revenue
Fair value change income
4.79%334.52K
129.33%2.06M
34.50%-4.13M
118.14%1.46M
103.65%319.23K
-168.64%-7.01M
-208.58%-6.3M
-154.07%-8.05M
-191.35%-8.75M
166.47%10.21M
Invest income
-74.71%3.29M
11.12%83.03M
30.56%73.35M
48.63%58.13M
-40.90%13.02M
-84.21%74.72M
-86.88%56.18M
-90.27%39.11M
-94.16%22.02M
426.07%473.27M
-Including: Investment income associates
129.18%995.59K
-8.82%8.17M
-29.29%3.9M
-18.00%2.07M
-23.81%434.42K
-36.85%8.96M
-49.40%5.52M
-74.84%2.52M
-90.65%570.16K
-47.10%14.19M
Asset deal income
---81.51K
-411.31%-1.6M
-446.99%-2.06M
-31,509.08%-2.06M
----
---312.75K
--594.48K
--6.57K
--881.17
----
Other revenue
16.07%9.3M
1.94%45.01M
4.14%32.68M
49.30%20.94M
-8.59%8.01M
16.58%44.16M
3.48%31.38M
232.66%14.03M
186.54%8.77M
132.34%37.88M
Operating profit
1.94%154.28M
-35.12%438.4M
-23.19%395.18M
-6.19%312.02M
22.86%151.34M
-29.72%675.68M
-34.60%514.46M
-48.21%332.62M
-74.15%123.18M
124.87%961.43M
Add:Non operating Income
-34.18%446.14K
6.59%3.34M
37.28%2.51M
-10.81%1.31M
-39.34%677.84K
-0.61%3.14M
-28.20%1.83M
-13.41%1.47M
106.79%1.12M
-14.01%3.15M
Less:Non operating expense
-20.40%21.41K
108.43%7.25M
3,060.61%6.07M
4,015.28%6.07M
-51.70%26.9K
-6.40%3.48M
-91.60%192.05K
-90.39%147.48K
-71.84%55.69K
-46.75%3.72M
Total profit
1.78%154.7M
-35.66%434.49M
-24.12%391.62M
-7.99%307.27M
22.34%151.99M
-29.72%675.34M
-34.41%516.1M
-48.02%333.94M
-73.95%124.24M
126.49%960.87M
Less:Income tax cost
2.93%12.85M
-64.60%22.43M
-49.61%25.98M
-27.20%23.05M
21.11%12.48M
-43.28%63.36M
-40.34%51.55M
-53.46%31.67M
-81.81%10.31M
178.47%111.7M
Net profit
1.68%141.85M
-32.67%412.06M
-21.29%365.65M
-5.97%284.21M
22.45%139.51M
-27.93%611.97M
-33.68%464.54M
-47.37%302.27M
-72.89%113.93M
121.07%849.17M
Net profit from continuing operation
1.68%141.85M
-32.67%412.06M
-21.29%365.65M
-5.97%284.21M
22.45%139.51M
-27.93%611.97M
-33.68%464.54M
-47.37%302.27M
-72.89%113.93M
121.07%849.17M
Less:Minority Profit
114.58%4.24M
-46.48%5.99M
172.66%8.44M
238.25%5.75M
383.74%1.97M
170.44%11.18M
36.96%3.1M
31.09%1.7M
17.26%408.23K
30.47%4.14M
Net profit of parent company owners
0.06%137.61M
-32.41%406.07M
-22.59%357.2M
-7.36%278.46M
21.15%137.54M
-28.90%600.79M
-33.91%461.45M
-47.55%300.57M
-72.96%113.52M
121.82%845.04M
Earning per share
Basic earning per share
2.33%0.44
-32.28%1.28
-22.60%1.13
-7.37%0.88
19.44%0.43
-29.21%1.89
-33.64%1.46
-47.51%0.95
-72.73%0.36
122.50%2.67
Diluted earning per share
2.33%0.44
-32.28%1.28
-22.60%1.13
-7.37%0.88
19.44%0.43
-28.95%1.89
-33.64%1.46
-47.51%0.95
-72.73%0.36
127.35%2.66
Other composite income
-86.99%12.75K
-42.97%-43.52M
-1,478.03%-30.52M
-1,395.84%-29.98M
175.66%98.06K
-135.67%-30.44M
-90.95%2.21M
-90.59%2.31M
-113.49%-129.61K
1,292.32%85.34M
Other composite income of parent company owners
-86.99%12.75K
-42.97%-43.52M
-1,478.03%-30.52M
-1,395.84%-29.98M
175.66%98.06K
-135.67%-30.44M
-90.95%2.21M
-90.59%2.31M
-113.49%-129.61K
1,292.32%85.34M
Total composite income
1.62%141.86M
-36.63%368.54M
-28.20%335.13M
-16.53%254.23M
22.68%139.61M
-37.77%581.53M
-35.61%466.76M
-49.15%304.58M
-72.98%113.8M
147.90%934.51M
Total composite income of parent company owners
-0.00%137.63M
-36.43%362.55M
-29.54%326.69M
-17.96%248.48M
21.38%137.63M
-38.70%570.35M
-35.84%463.66M
-49.32%302.88M
-73.05%113.39M
148.90%930.38M
Total composite income of minority owners
114.58%4.24M
-46.48%5.99M
172.66%8.44M
238.25%5.75M
383.74%1.97M
170.44%11.18M
36.96%3.1M
31.09%1.7M
17.26%408.23K
30.47%4.14M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
--
Auditor
--
Ernst & Young (Special General Partnership)
--
--
--
Ernst & Young (Special General Partnership)
--
--
--
Ernst & Young (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 0.04%686.91M-20.36%2.28B-12.00%1.83B0.20%1.27B21.87%686.67M34.72%2.86B36.52%2.08B36.63%1.27B36.22%563.45M51.63%2.13B
Operating revenue 0.04%686.91M-20.36%2.28B-12.00%1.83B0.20%1.27B21.87%686.67M34.72%2.86B36.52%2.08B36.63%1.27B36.22%563.45M51.63%2.13B
Total operating cost -3.33%538.74M-14.23%1.97B-6.87%1.53B5.84%1.03B20.72%557.27M35.84%2.29B37.09%1.64B38.19%977.88M41.28%461.61M56.00%1.69B
Operating cost 2.93%346.21M-24.17%1.13B-18.08%897.46M-1.45%613.8M20.67%336.35M40.10%1.48B46.09%1.1B35.86%622.8M35.37%278.74M52.69%1.06B
Operating tax surcharges -3.53%5.76M-7.90%20.81M-3.36%15.62M22.04%11.68M23.39%5.97M41.05%22.6M31.99%16.16M34.10%9.57M19.83%4.84M22.97%16.02M
Operating expense 0.14%80.48M-2.53%339.57M5.53%251.8M7.04%168.81M1.29%80.36M32.81%348.37M27.15%238.61M56.74%157.71M38.44%79.34M56.51%262.32M
Administration expense -9.93%41.04M10.95%183.47M20.30%135.91M28.57%93.72M35.38%45.57M31.53%165.35M32.95%112.97M29.28%72.89M22.29%33.66M76.68%125.71M
Financial expense -233.31%-12M-16.04%-23.53M55.31%-14.89M43.96%-10.63M400.30%9M-70.67%-20.28M-187.28%-33.33M-153.23%-18.97M68.06%-3M17.29%-11.88M
-Interest expense (Financial expense) -5.12%842.63K30.79%3.51M51.37%2.85M43.69%1.88M35.56%888.12K-7.16%2.69M-16.86%1.88M-20.35%1.31M112.22%655.16K3,369.39%2.89M
-Interest Income (Financial expense) -92.47%-13.04M-75.42%-35.61M-54.94%-23.94M-48.49%-14.58M-37.38%-6.77M-90.02%-20.3M-102.51%-15.45M-113.22%-9.82M-195.22%-4.93M54.03%-10.68M
Research and development -3.44%77.26M9.63%320.64M14.87%242.65M17.71%157.57M17.62%80.01M23.77%292.47M21.40%211.25M44.61%133.87M64.55%68.02M56.79%236.31M
Credit Impairment Loss -14,151.72%-6.73M-116.73%-2.42M-223.37%-993.68K-1,398.09%-431.24K154.00%47.88K-128.88%-1.12M444.54%805.42K-96.83%33.22K104.39%18.85K376.64%3.86M
Asset Impairment Loss -102.29%-12.5K69.64%-1.64M34.34%-1.46M39.43%-1.52M174.90%545.75K-307.43%-5.41M-358.74%-2.22M-544.18%-2.51M-2,536.08%-728.65K2.37%-1.33M
Other net revenue
Fair value change income 4.79%334.52K129.33%2.06M34.50%-4.13M118.14%1.46M103.65%319.23K-168.64%-7.01M-208.58%-6.3M-154.07%-8.05M-191.35%-8.75M166.47%10.21M
Invest income -74.71%3.29M11.12%83.03M30.56%73.35M48.63%58.13M-40.90%13.02M-84.21%74.72M-86.88%56.18M-90.27%39.11M-94.16%22.02M426.07%473.27M
-Including: Investment income associates 129.18%995.59K-8.82%8.17M-29.29%3.9M-18.00%2.07M-23.81%434.42K-36.85%8.96M-49.40%5.52M-74.84%2.52M-90.65%570.16K-47.10%14.19M
Asset deal income ---81.51K-411.31%-1.6M-446.99%-2.06M-31,509.08%-2.06M-------312.75K--594.48K--6.57K--881.17----
Other revenue 16.07%9.3M1.94%45.01M4.14%32.68M49.30%20.94M-8.59%8.01M16.58%44.16M3.48%31.38M232.66%14.03M186.54%8.77M132.34%37.88M
Operating profit 1.94%154.28M-35.12%438.4M-23.19%395.18M-6.19%312.02M22.86%151.34M-29.72%675.68M-34.60%514.46M-48.21%332.62M-74.15%123.18M124.87%961.43M
Add:Non operating Income -34.18%446.14K6.59%3.34M37.28%2.51M-10.81%1.31M-39.34%677.84K-0.61%3.14M-28.20%1.83M-13.41%1.47M106.79%1.12M-14.01%3.15M
Less:Non operating expense -20.40%21.41K108.43%7.25M3,060.61%6.07M4,015.28%6.07M-51.70%26.9K-6.40%3.48M-91.60%192.05K-90.39%147.48K-71.84%55.69K-46.75%3.72M
Total profit 1.78%154.7M-35.66%434.49M-24.12%391.62M-7.99%307.27M22.34%151.99M-29.72%675.34M-34.41%516.1M-48.02%333.94M-73.95%124.24M126.49%960.87M
Less:Income tax cost 2.93%12.85M-64.60%22.43M-49.61%25.98M-27.20%23.05M21.11%12.48M-43.28%63.36M-40.34%51.55M-53.46%31.67M-81.81%10.31M178.47%111.7M
Net profit 1.68%141.85M-32.67%412.06M-21.29%365.65M-5.97%284.21M22.45%139.51M-27.93%611.97M-33.68%464.54M-47.37%302.27M-72.89%113.93M121.07%849.17M
Net profit from continuing operation 1.68%141.85M-32.67%412.06M-21.29%365.65M-5.97%284.21M22.45%139.51M-27.93%611.97M-33.68%464.54M-47.37%302.27M-72.89%113.93M121.07%849.17M
Less:Minority Profit 114.58%4.24M-46.48%5.99M172.66%8.44M238.25%5.75M383.74%1.97M170.44%11.18M36.96%3.1M31.09%1.7M17.26%408.23K30.47%4.14M
Net profit of parent company owners 0.06%137.61M-32.41%406.07M-22.59%357.2M-7.36%278.46M21.15%137.54M-28.90%600.79M-33.91%461.45M-47.55%300.57M-72.96%113.52M121.82%845.04M
Earning per share
Basic earning per share 2.33%0.44-32.28%1.28-22.60%1.13-7.37%0.8819.44%0.43-29.21%1.89-33.64%1.46-47.51%0.95-72.73%0.36122.50%2.67
Diluted earning per share 2.33%0.44-32.28%1.28-22.60%1.13-7.37%0.8819.44%0.43-28.95%1.89-33.64%1.46-47.51%0.95-72.73%0.36127.35%2.66
Other composite income -86.99%12.75K-42.97%-43.52M-1,478.03%-30.52M-1,395.84%-29.98M175.66%98.06K-135.67%-30.44M-90.95%2.21M-90.59%2.31M-113.49%-129.61K1,292.32%85.34M
Other composite income of parent company owners -86.99%12.75K-42.97%-43.52M-1,478.03%-30.52M-1,395.84%-29.98M175.66%98.06K-135.67%-30.44M-90.95%2.21M-90.59%2.31M-113.49%-129.61K1,292.32%85.34M
Total composite income 1.62%141.86M-36.63%368.54M-28.20%335.13M-16.53%254.23M22.68%139.61M-37.77%581.53M-35.61%466.76M-49.15%304.58M-72.98%113.8M147.90%934.51M
Total composite income of parent company owners -0.00%137.63M-36.43%362.55M-29.54%326.69M-17.96%248.48M21.38%137.63M-38.70%570.35M-35.84%463.66M-49.32%302.88M-73.05%113.39M148.90%930.38M
Total composite income of minority owners 114.58%4.24M-46.48%5.99M172.66%8.44M238.25%5.75M383.74%1.97M170.44%11.18M36.96%3.1M31.09%1.7M17.26%408.23K30.47%4.14M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion--------
Auditor --Ernst & Young (Special General Partnership)------Ernst & Young (Special General Partnership)------Ernst & Young (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg